Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -12.96 | N/A |
| PEG Ratio (TTM) | 4.15 | N/A |
| P/S Ratio (TTM) | 1,250.15 | N/A |
| P/B Ratio (TTM) | 1.60 | N/A |
| P/FCF Ratio (TTM) | -15.92 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.86% | N/A |
| ROE (TTM) | -16.40% | N/A |
| Net Profit Margin (TTM) | -8,324.91% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.99% | -46,708.10% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -9.86% | -44,998.54% | N/A |
| Cash Flow | -3.52% | -47,835.16% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 27.63 | N/A |
| Quick Ratio (TTM) | 27.63 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | -9.14 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 27.76 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |